MPXI Stock Overview
MPX International Corporation, operates as a cannabis company in Canada and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
MPX International Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0 |
| 52 Week High | CA$0.01 |
| 52 Week Low | CA$0.005 |
| Beta | 0 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | n/a |
Recent News & Updates
Shareholder Returns
| MPXI | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | n/a | -1.8% | -0.6% |
| 1Y | n/a | 50.8% | 3.9% |
Return vs Industry: Insufficient data to determine how MPXI performed against the Canadian Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how MPXI performed against the Canadian Market.
Price Volatility
| MPXI volatility | |
|---|---|
| MPXI Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 13.9% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.3% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: MPXI has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MPXI's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | William Boyes | mpxinternationalcorp.com |
MPX International Corporation, operates as a cannabis company in Canada and internationally. It offers cannabis products under HOLYWEED, beleaf, SALSUS, MPX labs, Canveda, SPARTAN WELLNESS, HIGH12, STRAIN REE, PENNIES, Kingsway, DAIZE, and alice brands. The company was founded in 2015 and is headquartered in Toronto, Canada.
MPX International Corporation Fundamentals Summary
| MPXI fundamental statistics | |
|---|---|
| Market cap | CA$721.61k |
| Earnings (TTM) | -CA$28.36m |
| Revenue (TTM) | CA$6.69m |
0.0x
P/S Ratio0.0x
P/E RatioIs MPXI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MPXI income statement (TTM) | |
|---|---|
| Revenue | CA$6.69m |
| Cost of Revenue | CA$3.37m |
| Gross Profit | CA$3.33m |
| Other Expenses | CA$31.68m |
| Earnings | -CA$28.36m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did MPXI perform over the long term?
See historical performance and comparison